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Background
The A2A adenosine receptor has become a drug target
in the treatment of Parkinson’s disease, psychotic beha-
vior and dementia. In addition, targeted deletion of this
receptor in mice leads to hypertension, increased plate-
let aggregation, male aggressiveness and decreased sus-
ceptibility to ischemic brain damage. The potential
clinical relevance of this receptor is obvious. The A2A
adenosine receptor, a prototypical GPCR, is known to
signal via restricted collision coupling with Gs. In
addition, it is able to stimulate MAP kinase/ERK in a
Gs-independent way but dependent on the lipid micro-
environment of the membrane. Hence, we characterized
the mobility and the targeting of the A2A receptor in
nerve cells.
Methods
Receptor mobility was measured using fluorescence
recovery after photobleaching (FRAP). A fluorophore-
tagged version of the A2A receptor expressed in the cell
membrane was bleached using an intense laser beam
and the lateral diffusion rate of the receptor was deter-
mined. We also implemented the method of single
molecule tracking, which allows for the observation of
movements of single receptors in real spatial and tem-
poral resolution.
Results
We introduced a palmitoylation site in the proximal part
of the C-terminus of the A2A receptor; this led to the
loss of restricted collision coupling of the receptor to its
G protein. We also deleted a DVELL motif in the distal
part of the C-terminus, which disrupted the interaction
of the receptor with a “synaptic associated protein”
(SAP102). The mobility of these mutants has been
compared with wild-type A2A receptors in different
compartments of hippocampal neurons.
Conclusions
The signaling properties of the A2A adenosine receptor
depend on its localization within several membrane
compartments. Targeting to specific compartments
depends on the interaction with “accessory proteins”.
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